Allogene Therapeutics

ALLO • NASDAQ • Stock Fundamentals

Allogene Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David D. Chang, with a market cap of $731.7M.

Market Cap$731.7M

Employees361.0

CEODavid D. Chang

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Allogene Therapeutics

Allogene Therapeutics (ALLO) has a market capitalization of $731.7M and trades on NASDAQ.

Allogene Therapeutics has approximately 361 employees.